Neutrophil to lymphocyte ratio as a prognosis biomarker of PRRT in NET patients.

Beatriz Arruda Matheos de LimaRinaldo Gonçalves da SilvaCibele CarrollBruno VilhenaCarolina PerezRenata FelixMichel CarneiroLuiz Machado NetoFernanda VaismanRossana CorboPriscilla Brunelli PujattiDaniel Bulzico

Published in: Endocrine (2022)

Patients with advanced-stage NET with NLR higher than 1.8 have worse long term clinical outcomes after PPRT. Larger studies are needed to validate the optimal cutoff for this biomarker.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patient reported